IRVINE, Calif., May 3, 2006 (PRIMEZONE) -- "Analysts at the recent Bio 2006 Conference in Chicago were bullish in their sentiment regarding small cap biotech companies," said SmallCap Sentinel analyst D.R. Clark. "What's being reported is borderline zealous, with analysts from leading houses on the record extolling the fortunes of smaller drug companies."
"In fact, in a recent news release, Samaritan Pharmaceuticals, Inc. (AMEX:LIV) reported that Merrill Lynch VP of Biotechnology David W. Munno had stated that 'Large-cap biotech firms need some blockbuster products for meaningful growth which is more than likely to come from small- to mid-sized biotechs,' at the Bio 2006 conference," Clark added. "Other leading biotech analysts were similarly enthusiastic."
The informational report "The Silver Tsunami: Baby Boomers & Biotech Breakthroughs," is available at www.SmallCapSentinel.com and will address emergent and established biotech companies including Samaritan, BioMarin Pharmaceutical Inc., (Nasdaq:BMRN), Hana Biosciences Inc. (Nasdaq:HNAB), and The Immune Response Corporation (OTCBB:IMNR).
Samaritan is a drug development company driven to discover, develop and commercialize new, innovative drugs for AIDS, Alzheimer's, Cancer and Heart disease. Samaritan is currently advancing eight promising compounds out of its rich pipeline of 250 possible drug candidates, all of which have the potential to create revenue-generating opportunities.
A free detailed informational report regarding Samaritan is available at the following link: http://stockupticks.com/profiles/3-15-06.html
A Research Report on Samaritan Pharmaceuticals can be downloaded at the company's website: http://www.shareholder.com/samaritan/reports.cfm
Individuals may also register to receive future reports at: http://stockupticks.com/register.html
SmallCap Sentinel and StockUpTicks.com are publications of financial courier Market Pathways, a twenty-two year old full-service financial relations firm offering information on specific public companies to interested investors. To have your company featured in StockUpTicks or SmallCap Sentinel, please use the contact information below.
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect results. SmallCapSentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy or offer to sell securities but is rather a paid advertisement provided for information purposes only and shouldn't be used as the basis for investment decisions. MP is not an investment advisor and this report is not investment advice. MP was paid $9,500 and will receive additional payments totaling $9,500 by Samaritan Pharmaceuticals for preparation of this profile and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.